TWO VERSUS ONE DRUG FOR CONTROL OF SWELLING IN NEPHROTIC SYNDROME.
Not Applicable
- Conditions
- Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality
- Registration Number
- CTRI/2023/05/052552
- Lead Sponsor
- AIIMS Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed with Nephrotic Syndrome and presenting with moderate to severe edema (weight gain more than 8â??15%) admitted to IPD will be included in this study or clinical edema Grade 3+ or more
Exclusion Criteria
1. Congenital Nephrotic Syndrome
2. AKI
3. Hyponatremia,
4. Hypokalemia
5. Hypomagnesemia
6. Hypovolemia
7. Serum Albumin <1 gm/dl
8. Those who received diuretics before recruitment to the trial
9. Estimated glomerular filtration rate (eGFR) <=60 mL/min/1.73 m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method